| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Annals of Thoracic Surgery, Vol 38, 331-338, Copyright © 1984 by The Society of Thoracic Surgeons
PC Pairolero, DE Williams, EJ Bergstralh, JM Piehler, PE Bernatz and WS Payne
Three hundred forty-six patients with post-surgical non-small cell Stage I
bronchogenic carcinoma were followed from 5.0 to 10.8 years (median, 7.0
years). Recurrent cancer developed in 135 patients (39%). Seventy-five
recurrences were nonregional metastases (55.6%); 35 (25.9%), a subsequent
primary lung cancer; and 25 (18.5%), local recurrence only. The rate of
recurrent lung cancer decreased from 15.0 patients per 100 patient-years
the first postoperative year to 2.3 the seventh and subsequent years. The
rate of recurrence varied among the three different types of recurrent
cancer. Five years after pulmonary resection, 70.0% of patients with T1 N0
neoplasms had no evidence of recurrence compared with 58.2% of patients
with T2 N0 tumors (p = 0.012) and only 31.8% of patients with T1 N1
neoplasms (p less than 0.001). There was no significant difference in
overall rate of recurrence among the various cell types. Currently, 174
patients are alive. Lung cancer survival (Kaplan-Meier) was 69.1% at 5
years and 61.9% at 9 years. At 2 years following detection of subsequent
lung cancer, 51.8% of patients with subsequent primary lung cancer had
survived lung cancer compared with 23.4% for those with local recurrence
and only 8.9% for those with nonregional metastases.
ARTICLES
Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease
This article has been cited by other articles:
|
|
 |
|
  F. C. Detterbeck Critical Points When Using Vectors J. Clin. Oncol., October 20, 2009; 27(30): e166 - e166. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lee, R. M. van den Berg, S. Lam, A. F. Gazdar, K. Grunberg, A. McWilliams, J. LeRiche, P. E. Postmus, and T. G. Sutedja Color Fluorescence Ratio for Detection of Bronchial Dysplasia and Carcinoma In situ Clin. Cancer Res., July 15, 2009; 15(14): 4700 - 4705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Grodzki, J. Alchimowicz, A. Kozak, B. Kubisa, J. Pierog, J. Wojcik, M. Bielewicz, and D. Witkowska Additional pulmonary resections after pneumonectomy: actual long-term survival and functional results Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 493 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bordoni Consensus Conference: Multimodality Management of Early- and Intermediate-Stage Non-Small Cell Lung Cancer Oncologist, September 1, 2008; 13(9): 945 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-K. Hsu, H.-C. Huang, C.-C. Hsieh, H.-S. Hsu, Y.-C. Wu, M.-H. Huang, and W.-H. Hsu Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Ann. Thorac. Surg., December 1, 2007; 84(6): 1825 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Fernandez, C. K. Mehta, I. L. Kron, and V. E. Laubach Reinitiation of compensatory lung growth after subsequent lung resection. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1300 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-J. Hung, C.-Y. Wang, M.-H. Huang, B.-S. Huang, W.-H. Hsu, and Y.-C. Wu Prognostic factors in resected stage I non small cell lung cancer with a diameter of 3 cm or less: Visceral pleural invasion did not influence overall and disease-free survival J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 638 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rubins, M. Unger, and G. L. Colice Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 355S - 367S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Kim, J. G. Lee, C. Y. Lee, I.-k. Park, and K. Y. Chung Long-term Survival Following Pneumonectomy for Non-Small Cell Lung Cancer: Clinical Implications for Follow-up Care Chest, July 1, 2007; 132(1): 178 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jeremy George, A. K Banerjee, C. A Read, C. O'Sullivan, M. Falzon, F. Pezzella, A. G Nicholson, P. Shaw, G. Laurent, and P. H Rabbitts Surveillance for the detection of early lung cancer in patients with bronchial dysplasia Thorax, January 1, 2007; 62(1): 43 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Motohashi, A. Ishikawa, E. Ishikawa, M. Otsuji, T. Iizasa, H. Hanaoka, N. Shimizu, S. Horiguchi, Y. Okamoto, S.-i. Fujii, et al. A Phase I Study of In vitro Expanded Natural Killer T Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer Clin. Cancer Res., October 15, 2006; 12(20): 6079 - 6086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ganti, R. Milton, V. Anikin, and A. Thorpe Surgery for tumour recurrence in a pneumonectomy space. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 683 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Korst, A. L. Kansler, J. L. Port, P. C. Lee, and N. K. Altorki Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer. Ann. Thorac. Surg., September 1, 2006; 82(3): 1009 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Guo, Y. Ma, R. Ward, V. Castranova, X. Shi, and Y. Qian Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma. Clin. Cancer Res., June 1, 2006; 12(11): 3344 - 3354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sugimura and P. Yang Long-term Survivorship in Lung Cancer: A Review. Chest, April 1, 2006; 129(4): 1088 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lai Endoscopic Ultrasound-Guided Fine Needle Aspiration for Diagnosis of Recurrent Nonsmall Cell Lung Cancer Ann. Thorac. Surg., December 1, 2005; 80(6): 2346 - 2349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Visbal, N. B. Leighl, R. Feld, and F. A. Shepherd Adjuvant Chemotherapy for Early-Stage Non-small Cell Lung Cancer Chest, October 1, 2005; 128(4): 2933 - 2943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Bogart and J. N. Aronowitz Localized Non-Small Cell Lung Cancer: Adjuvant Radiotherapy in the Era of Effective Systemic Therapy Clin. Cancer Res., July 1, 2005; 11(13): 5004s - 5010s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. V. Scagliotti and on behalf of the Adjuvant Lung Cancer Project Ital The ALPI Trial: The Italian/European Experience with Adjuvant Chemotherapy in Resectable Non-Small Lung Cancer Clin. Cancer Res., July 1, 2005; 11(13): 5011s - 5016s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ishikawa, S. Motohashi, E. Ishikawa, H. Fuchida, K. Higashino, M. Otsuji, T. Iizasa, T. Nakayama, M. Taniguchi, and T. Fujisawa A Phase I Study of {alpha}-Galactosylceramide (KRN7000)-Pulsed Dendritic Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer Clin. Cancer Res., March 1, 2005; 11(5): 1910 - 1917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Terzi, A. Lonardoni, P. Scanagatta, S. Pergher, C. Bonadiman, and F. Calabro Lung resection for bronchogenic carcinoma after pneumonectomy: a safe and worthwhile procedure Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 456 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Chen, T. G Gharib, H. Wang, C.-C. Huang, R. Kuick, D. G. Thomas, K. A. Shedden, D. E. Misek, J. M. G. Taylor, T. J. Giordano, et al. Protein profiles associated with survival in lung adenocarcinoma PNAS, November 11, 2003; 100(23): 13537 - 13542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rice, H.-W. Kim, A. Sabichi, S. Lippman, J. J. Lee, B. Williams, A. Vaporciyan, W. R. Smythe, S. Swisher, G. Walsh, et al. The risk of second primary tumors after resection of Stage I nonsmall cell lung cancer Ann. Thorac. Surg., October 1, 2003; 76(4): 1001 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. V. Scagliotti, R. Fossati, V. Torri, L. Crino, G. Giaccone, G. Silvano, M. Martelli, M. Clerici, F. Cognetti, and M. Tonato Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer J Natl Cancer Inst, October 1, 2003; 95(19): 1453 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A K Banerjee, P H Rabbitts, and J George Lung cancer * 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities Thorax, March 1, 2003; 58(3): 266 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Swensen, J. R. Jett, T. E. Hartman, D. E. Midthun, J. A. Sloan, A.-M. Sykes, G. L. Aughenbaugh, and M. A. Clemens Lung Cancer Screening with CT: Mayo Clinic Experience Radiology, March 1, 2003; 226(3): 756 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sutedja New techniques for early detection of lung cancer Eur. Respir. J., January 1, 2003; 21(39_suppl): 57S - 66s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Colice, J. Rubins, and M. Unger Follow-up and Surveillance of the Lung Cancer Patient Following Curative-Intent Therapy Chest, January 1, 2003; 123 (2009): 272S - 283S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Lamont, J. T. Kakuda, D. Smith, L. D. Wagman, and F. W. Grannis Jr Systematic Postoperative Radiologic Follow-up in Patients With Non-Small Cell Lung Cancer for Detecting Second Primary Lung Cancer in Stage IA Arch Surg, August 1, 2002; 137(8): 935 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Donington, D. L. Miller, C. C. Rowland, C. Deschamps, M. S. Allen, V. F. Trastek, and P. C. Pairolero Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy Ann. Thorac. Surg., July 1, 2002; 74(1): 154 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Miller, C. M. Rowland, C. Deschamps, M. S. Allen, V. F. Trastek, and P. C. Pairolero Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Ann. Thorac. Surg., May 1, 2002; 73(5): 1545 - 1551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Rena, A. Oliaro, A. Cavallo, P. L. Filosso, G. Donati, P. Di Marzio, G. Maggi, and E. Ruffini Stage I non-small cell lung carcinoma: really an early stage? Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 514 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Aziz, R. A. Saad, J. Glasser, A. N. Jilaihawi, and D. Prakash The management of second primary lung cancers. A single centre experience in 15 years Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 527 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. SWENSEN, J. R. JETT, J. A. SLOAN, D. E. MIDTHUN, T. E. HARTMAN, A.-M. SYKES, G. L. AUGHENBAUGH, F. E. ZINK, S. L. HILLMAN, G. R. NOETZEL, et al. Screening for Lung Cancer with Low-Dose Spiral Computed Tomography Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 508 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.F. Vansteenkiste Imaging in lung cancer: positron emission tomography scan Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rea, A. Zuin, D. Callegaro, L. Bortolotti, G. Guanella, and F. Sartori Surgical results for multiple primary lung cancers Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 489 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Mineo, V. Ambrogi, V. Corsaro, and M. Roselli Postoperative adjuvant therapy for stage IB non-small-cell lung cancer Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 378 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman, J. J. Lee, D. D. Karp, E. E. Vokes, S. E. Benner, G. E. Goodman, F. R. Khuri, R. Marks, R. J. Winn, W. Fry, et al. Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer J Natl Cancer Inst, April 18, 2001; 93(8): 605 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.F. Vansteenkiste and S.G. Stroobants The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Eur. Respir. J., April 1, 2001; 17(4): 802 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kara, Y. Ohta, Y. Tanaka, M. Oda, and Y. Watanabe Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer Ann. Thorac. Surg., March 1, 2001; 71(3): 944 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.-Y. Hsu, H.-C. Ho, K.-C. Chow, T.-Y. Lin, C.-S. Shih, L.-S. Wang, and C.-M. Tsai Overexpression of Dihydrodiol Dehydrogenase as a Prognostic Marker of Non-Small Cell Lung Cancer Cancer Res., March 1, 2001; 61(6): 2727 - 2731. [Abstract] [Full Text]
|
|
|
|
|
|
B. Jeremic, Y. Shibamoto, L. Acimovic, N. Nikolic, A. Dagovic, J. Aleksandrovic, and G. Radosavljevic-Asic Second Cancers Occurring in Patients With Early Stage Non-Small-Cell Lung Cancer Treated With Chest Radiation Therapy Alone J. Clin. Oncol., February 15, 2001; 19(4): 1056 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gunen, O. Kizkin, C. Tahaoglu, and O. Aktas Utility of Blind Forceps Biopsy of the Main Carina and Upper-Lobe Carina in Patients With Non-small Cell Lung Cancer Chest, February 1, 2001; 119(2): 632 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Asaph, J. F. Keppel, J. R. Handy Jr., E. C. Douville, A. C. Tsen, and G. Y. Ott Surgery for Second Lung Cancers Chest, December 1, 2000; 118(6): 1621 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Voltolini, P. Paladini, L. Luzzi, C. Ghiribelli, M. Di Bisceglie, and G. Gotti Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma Eur. J. Cardiothorac. Surg., November 1, 2000; 18(5): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Granone, L. Trodella, S. Margaritora, A. Cesario, G. M. Corbo, G. Mantini, M. Balducci, and G. Fumagalli Radiotherapy versus follow-up in the treatment of pathological stage Ia and Ib non-small cell lung cancer. Early stopped analysis of a randomized controlled study Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 418 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gilbert, K. R. Reid, M. Y. Lam, and D. Petsikas Who should follow up lung cancer patients after operation? Ann. Thorac. Surg., June 1, 2000; 69(6): 1696 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Deslauriers and J. Gregoire Surgical Therapy of Early Non-Small Cell Lung Cancer Chest, April 1, 2000; 117 (2009): 104S - 109S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wagner Jr Postoperative Adjuvant Therapy for Patients With Resected Non-Small Cell Lung Cancer: Still Controversial After all These Years Chest, April 1, 2000; 117 (2009): 110S - 118S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Younes, J. L. Gross, and D. Deheinzelin Follow-up in Lung Cancer: How Often and for What Purpose? Chest, June 1, 1999; 115(6): 1494 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. D'Amico, MD, M. Massey, MD, J. E. Herndon II, PhD, M.-B. Moore, and D. H. Harpole Jr A BIOLOGIC RISK MODEL FOR STAGE I LUNG CANCER: IMMUNOHISTOCHEMICAL ANALYSIS OF 408 PATIENTS WITH THE USE OF TEN MOLECULAR MARKERS J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 736 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Martini, V. W. Rusch, M. S. Bains, M. G. Kris, R. J. Downey, B. J. Flehinger, and R. J. Ginsberg FACTORS INFLUENCING TEN-YEAR SURVIVAL IN RESECTED STAGES I TO IIIA NON-SMALL CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 32 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Leong, C. M. Rocha Lima, C. A. Sherman, and M. R. Green The 1997 International Staging System for Non-Small Cell Lung Cancer: Have All the Issues Been Addressed? Chest, January 1, 1999; 115(1): 242 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Hsieh, K.-C. Chow, H.-J. Fahn, C.-M. Tsai, W.-Y. Li, M.-H. Huang, and L.-S. Wang Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung Ann. Thorac. Surg., October 1, 1998; 66(4): 1159 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okada, N. Tsubota, M. Yoshimura, and Y. Miyamoto Operative approach for multiple primary lung carcinomas J. Thorac. Cardiovasc. Surg., April 1, 1998; 115(4): 836 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mitsudomi, Y. Yatabe, T. Koshikawa, S. Hatooka, M. Shinoda, M. Suyama, T. Sugiura, M. Ogawa, and T. Takahashi MUTATIONS OF THE P53 TUMOR SUPPRESSOR GENE AS CLONAL MARKER FOR MULTIPLE PRIMARY LUNG CANCERS J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 354 - 360. [Abstract] [Full Text]
|
|
|
|
|
|
R. J. Landreneau, D. J. Sugarbaker, M. J. Mack, S. R. Hazelrigg, J. D. Luketich, L. Fetterman, M. J. Liptay, S. Bartley, T. M. Boley, R. J. Keenan, et al. WEDGE RESECTION VERSUS LOBECTOMY for STAGE I (T1 N0 M0) NON-SMALL-CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., April 1, 1997; 113(4): 691 - 700. [Abstract] [Full Text]
|
|
|
|
|
|
W.-W. Lai, M.-H. Wu, J.-J. Yan, and F.-F. Chen Immunohistochemical Analysis of nm23-H1 in Stage I Non-Small Cell Lung Cancer: A Useful Marker in Prediction of Metastases Ann. Thorac. Surg., November 1, 1996; 62(5): 1500 - 1504. [Abstract] [Full Text]
|
|
|
|
|
|
K. S. Virgo, K. S. Naunheim, L. W. McKirgan, M. E. Kissling, J. C. Lin, and F. E. Johnson COST OF PATIENT FOLLOW-UP AFTER POTENTIALLY CURATIVE LUNG CANCER TREATMENT J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 356 - 363. [Abstract] [Full Text]
|
|
|
|
|
|
H. Asamura, H. Nakayama, H. Kondo, R. Tsuchiya, Y. Shimosato, and T. Naruke LYMPH NODE INVOLVEMENT, RECURRENCE, AND PROGNOSIS IN RESECTED SMALL, PERIPHERAL, NON-SMALL-CELL LUNG CARCINOMAS: ARE THESE CARCINOMAS CANDIDATES FOR VIDEO-ASSISTED LOBECTOMY? J. Thorac. Cardiovasc. Surg., June 1, 1996; 111(6): 1125 - 1134. [Abstract] [Full Text]
|
|
|
|
|
|
D. H. Harpole Jr, W. G. Richards, J. E. Herndon II, and D. J. Sugarbaker Angiogenesis and Molecular Biologic Substaging in Patients With Stage I Non-Small Cell Lung Cancer Ann. Thorac. Surg., May 1, 1996; 61(5): 1470 - 1476. [Abstract] [Full Text]
|
|
|
|
|
|
K. Yokoi, N. Miyazawa, and T. Arai Brain Metastasis in Resected Lung Cancer: Value of Intensive Follow-up With Computed Tomography Ann. Thorac. Surg., February 1, 1996; 61(2): 546 - 550. [Abstract] [Full Text]
|
|
|
|
|
|
K. S. Naunheim, K. S. Virgo, M. A. Coplin, and F. E. Johnson Clinical Surveillance Testing After Lung Cancer Operations Ann. Thorac. Surg., December 1, 1995; 60(6): 1612 - 1616. [Abstract] [Full Text]
|
|
|
|
|
|
L. E. Stenbygaard, J. B. Sorensen, and J. E. Olsen METASTATIC PATTERN IN ADENOCARCINOMA OF THE LUNG An autopsy study from a cohort of 137 consecutive patients with complete resection J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1130 - 1135. [Abstract] [Full Text]
|
|
|
|
|
|
A. K. Vaaler, H. O. Hosannah, and R. B. Wagner Pneumonectomy After Contralateral Lobectomy: Is It Reasonable? Ann. Thorac. Surg., January 1, 1995; 59(1): 178 - 182. [Abstract] [Full Text]
|
|
|
|
|
|
G. Massard, G. Lyons, J.-M. Wihlm, P. Fernoux, P. Dumont, R. Kessler, N. Roeslin, and G. Morand Early and Long-Term Results After Completion Pneumonectomy Ann. Thorac. Surg., January 1, 1995; 59(1): 196 - 200. [Abstract] [Full Text]
|
|
|
|
|
|
T. Funatsu, Y. Matsubara, S. Ikeda, R. Hatakenaka, T. Hanawa, and H. Ishida Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 321 - 328. [Abstract] [Full Text]
|
|
|
|
|
|
R. J. Mehran, J. Deslauriers, M. Piraux, M. Beaulieu, C. Guimont, and J. Brisson Survival related to nodal status after sleeve resection for lung cancer J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 576 - 583. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
